C
Cynthia Kendrick
Researcher at Cleveland Clinic
Publications - 14
Citations - 844
Cynthia Kendrick is an academic researcher from Cleveland Clinic. The author has contributed to research in topics: Kidney disease & Renal function. The author has an hindex of 11, co-authored 14 publications receiving 727 citations.
Papers
More filters
Journal ArticleDOI
Disparate Estimates of Hypertension Control From Ambulatory and Clinic Blood Pressure Measurements in Hypertensive Kidney Disease
Velvie A. Pogue,Mahboob Rahman,Michael S. Lipkowitz,Robert D. Toto,Edgar R. Miller,Marquetta Faulkner,Stephen G. Rostand,Leena Hiremath,Mohammed Sika,Cynthia Kendrick,Bo Hu,Tom Greene,Lawrence J. Appel,Robert A. Phillips +13 more
TL;DR: Clinical BP provides an incomplete and potentially misleading assessment of the severity of hypertension in African Americans with hypertensive kidney disease, in large part because of increased nighttime BP.
Journal ArticleDOI
Effects of Frequent Hemodialysis on Measures of CKD Mineral and Bone Disorder
John T. Daugirdas,Glenn M. Chertow,Brett Larive,Andreas Pierratos,Tom Greene,Juan Carlos Ayus,Cynthia Kendrick,Sam James,Brent W. Miller,Gerald Schulman,Isidro B. Salusky,Alan S. Kliger +11 more
TL;DR: In conclusion, frequent hemodialysis facilitates control of hyperphosphatemia and extended session lengths could allow more liberal diets and freedom from phosphorus binders.
Journal ArticleDOI
Risk of hyperkalemia in nondiabetic patients with chronic kidney disease receiving antihypertensive therapy.
Joy M. Weinberg,Lawrence J. Appel,George L. Bakris,Jennifer J. Gassman,Tom Greene,Cynthia Kendrick,Xuelei Wang,James P. Lash,Julia A. Lewis,Velvie A. Pogue,Denyse Thornley-Brown,Robert A. Phillips +11 more
TL;DR: In nondiabetic patients with hypertensive CKD treated with ACEIs, the risk of hyperkalemia is small, particularly if baseline and follow-up GFR is higher than 40 mL/min/1.73 m(2), and including a diuretic in the regimen may markedly reduce risk.
Journal ArticleDOI
A Trial of 2 Strategies to Reduce Nocturnal Blood Pressure in Blacks With Chronic Kidney Disease
Mahboob Rahman,Tom Greene,Robert A. Phillips,Lawrence Y. Agodoa,George L. Bakris,Jeanne Charleston,Gabriel Contreras,Francis B. Gabbai,Leena Hiremath,Kenneth Jamerson,Cynthia Kendrick,John W. Kusek,James P. Lash,Janice P. Lea,Edgar R. Miller,Stephen G. Rostand,Robert D. Toto,Xulei Wang,Jackson T. Wright,Lawrence J. Appel +19 more
TL;DR: In this paper, the effects of two antihypertensive drug dose schedules (PM dose and add-on dose) on nocturnal blood pressure (BP) in comparison with usual therapy (AM dose) in blacks with hypertensive chronic kidney disease and controlled office BP were determined.
Journal ArticleDOI
BP in Dialysis: Results of a Pilot Study.
Dana C. Miskulin,Jennifer J. Gassman,Ronald M. Schrader,Ambreen Gul,Manisha Jhamb,David W. Ploth,Lavinia Negrea,Raymond Y. Kwong,Andrew S. Levey,Ajay K. Singh,Antonia Harford,Antonia Harford,Susan Paine,Cynthia Kendrick,Mahboob Rahman,Philip G. Zager,Philip G. Zager +16 more
TL;DR: Although the small size and short duration of the trial prevent definitive conclusions, a full-scale trial is needed to assess potential benefits of intensive hypertension control in this population.